TCR-T 2025 – From Proof to Platform
The TCR-T cell therapy field is no longer defined by scientific potential, but by industrial execution. As 2025 closes, the sector is undergoing a profound reset – marked by landmark validation, strategic consolidation, and a technological arms race. This market intelligence briefing analyzes the critical shifts in the landscape and the leadership imperatives required to […]